CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder
Yankai Xu, Ruihua Liu, Chu Liu, Yuanshan Cui, Zhenli Gao
Int Neurourol J. 2017;21(3):212-219.   Published online 2017 September 12
DOI: https://doi.org/10.5213/inj.1734934.467

Excel Download

Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder
International Neurourology Journal. 2017;21(3):212-219   Crossref logo
Link1 Link2 Link3

Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)
European Urology. 2016;70(5):892   Crossref logo
Link1 Link2

Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-Blind Multicentre Phase 3B Study (BESIDE)
The Journal of Urology. 2017;197(3):767-768   Crossref logo
Link1 Link2

PD26-06 EFFICACY AND SAFETY OF MIRABEGRON ADD-ON THERAPY TO SOLIFENACIN IN OLDER PATIENT POPULATIONS WITH OVERACTIVE BLADDER
The Journal of Urology. 2017;197(4):e508   Crossref logo
Link1 Link2

Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)
European Urology. 2016;70(1):136-145   Crossref logo
Link1 Link2

Combination of solifenacin and mirabegron for overactive bladder management
BJU International. 2015;116(4):498-499   Crossref logo
Link1

Assessing Change In Health-Related Quality Of Life With Mirabegron Add-On Therapy To Solifenacin In Incontinent Patients With Overactive Bladder: An Analysis Of Eq 5d-5l And Oab-5d Data From The Beside Clinical Trial
Value in Health. 2016;19(3):A132   Crossref logo
Link1 Link2

Urodynamic Efficacy and Safety of Mirabegron Add-on Treatment with Tamsulosin for Japanese Male Patients with Overactive Bladder
LUTS: Lower Urinary Tract Symptoms. 2015;8(3):171-176   Crossref logo
Link1

Mirabegron in overactive bladder patients: efficacy review and update on drug safety
Therapeutic Advances in Drug Safety. 2016;7(5):204-216   Crossref logo
Link1 Link2 Link3

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability
Neurourology and Urodynamics. 2013;33(1):17-30   Crossref logo
Link1